Voters should care about this bill because it addresses a long-standing concern about conflicts of interest in the prescription drug market, particularly within the system that provides health benefits to federal workers. Currently, some companies involved in providing health insurance or managing drug benefits also own the pharmacies where people fill their prescriptions. This setup can create an incentive for these integrated companies to steer patients to their own pharmacies, potentially limiting competition, restricting patient choice, and obscuring the true cost of medications.

If this bill becomes law, it could foster more competition among pharmacies and Pharmacy Benefit Managers by untangling these ownership structures for federal employee health plans. This separation might lead to more transparent drug pricing and potentially lower out-of-pocket costs for federal employees. If the bill does not pass, the existing integrated ownership models would continue, and the concerns about self-dealing and limited competition within the FEHB program would likely persist.